Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Pilot Project Competition Awards Announced
PHILADELPHIA (January 6, 2020) – Fox Chase Cancer Center has announced the results of this year’s Pilot Project competition, which is supported in large part by the generosity of donors attending the center’s signature fundraising event, In Vino Vita. Supplemental funding was provided by Fox Chase’s National Cancer Institute Cancer Center Support Grant (CCSG). The award is effective from January 1, 2020 through December 31, 2021.
The goal of the Pilot Project competition was to identify and support team-based translational projects with high potential to lead to grants with multiple principal investigators such as Specialized Programs of Research Excellence (SPORE) grants or Program Project Grants (PPG).
Proposed studies of particular interest were those that addressed cutting-edge issues in organ-based diseases such as lung or gastrointestinal/pancreas cancers or focused on high-priority oncogenic pathways such as RAS or BRCA.
This year, two pilot projects were awarded to center faculty members. The awardees are:
- Margie Clapper, PhD, Joseph Treat, MD, and Andrew Andrews, PhD, for their proposal, “Oncogenic Properties of Estrogen Metabolites in Never-Smokers with Non-Small Cell Lung Cancer.”
- Joan Font-Burgada, PhD, and Hossein Borghaei, DO, MS, for their proposal, “Investigating Neoantigen-Specific Memory T-Cells to Develop Highly Efficient Anticancer Therapies.”
The competition was open to Fox Chase and Temple University researchers who have a formal appointment to one of the CCSG research programs.
Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 888-369-2427